China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)

China · Delayed Price · Currency is CNY

23.00

+0.12 (0.52%)

Oct 16, 2026, 3:00 PM CST

Market Cap	14.48B +6.2%
Revenue (ttm)	4.01B -6.8%
Net Income	875.75M +7.2%
EPS	1.39 +8.2%
Shares Out	629.44M
PE Ratio	16.56
Forward PE	15.48
Dividend	1.38 (6.00%)
Ex-Dividend Date	Sep 11, 2026

Volume	4,477,661
Open	23.02
Previous Close	22.88
Day's Range	22.83 - 23.30
52-Week Range	21.05 - 27.83
Beta	-0.08
Analysts	Strong Buy
Price Target	29.13 (+26.65%)
Earnings Date	Oct 24, 2026

About SHA:600750

China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, fritillaria and loquat capsules, bezoar and snake gallbladder fritillaria liquid, and compound gold melon seed. It also provides health consumer and other products, such as nouris... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1996

Employees 4,352

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600750

Full Company Profile

Financial Performance

In 2025, SHA:600750's revenue was 4.22 billion, a decrease of -4.87% compared to the previous year's 4.44 billion. Earnings were 906.69 million, an increase of 15.03%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 600750 stock is "Strong Buy." The 12-month stock price target is ¥29.13, which is an increase of 26.65% from the latest price.

Price Target

¥29.13

(26.65% upside)

Analyst Consensus: Strong Buy

Stock Forecasts